BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments

  November 5, 2025

   · 

  14 min read
• Press Releases

  Teva’s Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

  November 5, 2025

   · 

  57 min read
• Press Releases

  MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

  November 5, 2025

   · 

  22 min read
• Press Releases

  Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

  November 5, 2025

   · 

  16 min read
• Press Releases

  Larimar Therapeutics Reports Third Quarter 2025 Financial Results

  November 5, 2025

   · 

  14 min read
• Press Releases

  Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress

  November 5, 2025

   · 

  12 min read
• Press Releases

  Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025

  November 5, 2025

   · 

  7 min read
• Press Releases

  Sionna Therapeutics Reports Third Quarter 2025 Financial Results

  November 5, 2025

   · 

  10 min read
• Press Releases

  Skye Bioscience to Announce Third Quarter 2025 Financial Results and Business Update on November 10, 2025

  November 5, 2025

   · 

  1 min read
• Press Releases

  Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update

  November 5, 2025

   · 

  11 min read